Wellington Management Group LLP Sells 7,707 Shares of The Cooper Companies, Inc. $COO

Key Points

• Wellington Management Group LLP reduced its stake in The Cooper Companies by 4.4%, owning approximately 167,445 shares worth $14.12 million after selling 7,707 shares in the first quarter.
• The Cooper Companies reported $1 billion in revenue for the last quarter, exceeding analysts' expectations, with an EPS of $0.96 compared to the consensus estimate of $0.93.
• Wall Street analysts have a consensus rating of "Moderate Buy" for The Cooper Companies, with varying price targets, including $94.00 and $100.00 from different firms.

Wellington Management Group LLP decreased its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 4.4% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 167,445 shares of the medical device company's stock after selling 7,707 shares during the quarter. Wellington Management Group LLP owned about 0.08% of Cooper Companies worth $14,124,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Zions Bancorporation National Association UT acquired a new position in shares of Cooper Companies during the 1st quarter worth approximately $33,000. City Holding Co. acquired a new position in shares of Cooper Companies during the 1st quarter worth approximately $34,000. GKV Capital Management Co. Inc. acquired a new position in shares of Cooper Companies during the 1st quarter worth approximately $40,000. Larson Financial Group LLC increased its position in shares of Cooper Companies by 1,071.0% during the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after purchasing an additional 664 shares during the last quarter. Finally, HM Payson & Co. increased its position in shares of Cooper Companies by 147.4% during the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after purchasing an additional 532 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Analysts Set New Price Targets

A number of research analysts recently weighed in on COO shares. JPMorgan Chase & Co. decreased their target price on Cooper Companies from $76.00 to $66.00 and set a "neutral" rating on the stock in a report on Thursday. Piper Sandler decreased their target price on Cooper Companies from $105.00 to $83.00 and set an "overweight" rating on the stock in a report on Thursday. BNP Paribas raised Cooper Companies from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 22nd. Needham & Company LLC reissued a "buy" rating and set a $94.00 target price on shares of Cooper Companies in a report on Thursday. Finally, Loop Capital set a $100.00 target price on Cooper Companies in a report on Tuesday, June 17th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $86.64.

Cooper Companies Stock Performance

COO traded up $2.81 during trading on Monday, hitting $67.39. The stock had a trading volume of 4,071,437 shares, compared to its average volume of 2,729,446. The company has a 50 day moving average price of $72.29 and a 200-day moving average price of $77.29. The firm has a market cap of $13.40 billion, a price-to-earnings ratio of 33.20, a P/E/G ratio of 1.63 and a beta of 0.97. The Cooper Companies, Inc. has a one year low of $61.78 and a one year high of $112.38. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.03. The business had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The firm's quarterly revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.